FGF23 and chronic kidney disease: An increase in the FGF23 level is recognized in the pathogenesis of secondary hyperparathyroidism with low 1,25(OH)2D3, hyperphosphatemia, and hypocalcemia in patients with advanced chronic kidney diseases [133].